Literature DB >> 25661032

Atrial remodeling, fibrosis, and atrial fibrillation.

José Jalife1, Kuljeet Kaur2.   

Abstract

The fundamental mechanisms governing the perpetuation of atrial fibrillation (AF), the most common arrhythmia seen in clinical practice, are poorly understood, which explains in part why AF prevention and treatment remain suboptimal. Although some clinical parameters have been identified as predicting a transition from paroxysmal to persistent AF in some patients, the molecular, electrophysiological, and inflammation changes leading to such a progression have not been described in detail. Oxidative stress, atrial dilatation, calcium overload, inflammation, microRNAs, and myofibroblast activation are all thought to be involved in AF-induced atrial remodeling. However, it is unknown to what extent and at which time points such alterations influence the remodeling process that perpetuates AF. Here we postulate a working model that might open new pathways for future investigation into mechanisms of AF perpetuation. We start from the premise that the progression to AF perpetuation is the result of interplay among manifold signaling pathways with differing kinetics. Some such pathways have relatively fast kinetics (e.g., oxidative stress-mediated shortening of refractory period); others likely depend on molecular processes with slower kinetics (e.g., transcriptional changes in myocyte ion channel protein expression mediated through inflammation and fibroblast activation). We stress the need to fully understand the relationships among such pathways should one hope to identify novel, truly effective targets for AF therapy and prevention.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25661032      PMCID: PMC5658790          DOI: 10.1016/j.tcm.2014.12.015

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  98 in total

1.  Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers.

Authors:  Sharon Zlochiver; Viviana Muñoz; Karen L Vikstrom; Steven M Taffet; Omer Berenfeld; José Jalife
Journal:  Biophys J       Date:  2008-07-25       Impact factor: 4.033

Review 2.  Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation.

Authors:  S Nattel
Journal:  Cardiovasc Res       Date:  1999-05       Impact factor: 10.787

3.  Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution.

Authors:  A C Nag
Journal:  Cytobios       Date:  1980

Review 4.  Assembly and signaling of adhesion complexes.

Authors:  Jorge L Sepulveda; Vasiliki Gkretsi; Chuanyue Wu
Journal:  Curr Top Dev Biol       Date:  2005       Impact factor: 4.897

5.  MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation.

Authors:  Kristin Dawson; Reza Wakili; Balázs Ordög; Sebastian Clauss; Yu Chen; Yuki Iwasaki; Niels Voigt; Xiao Yan Qi; Moritz F Sinner; Dobromir Dobrev; Stefan Kääb; Stanley Nattel
Journal:  Circulation       Date:  2013-03-04       Impact factor: 29.690

Review 6.  Atrial fibrillation from the pathologist's perspective.

Authors:  Domenico Corradi
Journal:  Cardiovasc Pathol       Date:  2013-12-15       Impact factor: 2.185

7.  Evidence of intercellular coupling between co-cultured adult rabbit ventricular myocytes and myofibroblasts.

Authors:  Lisa Chilton; Wayne R Giles; Godfrey L Smith
Journal:  J Physiol       Date:  2007-06-14       Impact factor: 5.182

8.  Chronic atrial fibrillation increases microRNA-21 in human atrial myocytes decreasing L-type calcium current.

Authors:  Adriana Barana; Marcos Matamoros; Pablo Dolz-Gaitón; Marta Pérez-Hernández; Irene Amorós; Mercedes Núñez; Sandra Sacristán; Álvaro Pedraz; Ángel Pinto; Francisco Fernández-Avilés; Juan Tamargo; Eva Delpón; Ricardo Caballero
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-08-08

9.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13

10.  Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins.

Authors:  Svetlana N Reilly; Raja Jayaram; Keshav Nahar; Charalambos Antoniades; Sander Verheule; Keith M Channon; Nicholas J Alp; Ulrich Schotten; Barbara Casadei
Journal:  Circulation       Date:  2011-08-15       Impact factor: 29.690

View more
  84 in total

1.  Myeloperoxidase in atrial fibrillation: association with progression, origin and influence of renin-angiotensin system antagonists.

Authors:  Erik Holzwirth; Jelena Kornej; Sandra Erbs; Danilo Obradovic; Andreas Bollmann; Gerhard Hindricks; Holger Thiele; Petra Büttner
Journal:  Clin Res Cardiol       Date:  2019-06-24       Impact factor: 5.460

2.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

3.  LIM kinase 1 acts as a profibrotic mediator in permanent atrial fibrillation patients with valvular heart disease.

Authors:  Qinhua Chen; Ryan C Gimple; Guannan Li; Jianzhou Chen; Han Wu; Ran Li; Jun Xie; Biao Xu
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

4.  Is TGF-β1 (Transforming Growth Factor-β1) an Enabler of Myofibroblast-Cardiomyocyte Cross Talk?

Authors:  Kuljeet Kaur; José Jalife
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-05

5.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

6.  Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation.

Authors:  Padmini Sirish; Ning Li; Valeriy Timofeyev; Xiao-Dong Zhang; Lianguo Wang; Jun Yang; Kin Sing Stephen Lee; Ahmed Bettaieb; Sin Mei Ma; Jeong Han Lee; Demetria Su; Victor C Lau; Richard E Myers; Deborah K Lieu; Javier E López; J Nilas Young; Ebenezer N Yamoah; Fawaz Haj; Crystal M Ripplinger; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-05

Review 7.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Europace       Date:  2018-01-01       Impact factor: 5.214

8.  Advances in cardiac cellular electrophysiology - Relevance for clinical translation.

Authors:  Ursula Ravens; Andreas Goette
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-03

Review 9.  Mechanisms and Drug Development in Atrial Fibrillation.

Authors:  David Calvo; David Filgueiras-Rama; José Jalife
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 10.  Is extensive atrial fibrosis in the setting of heart failure associated with a reduced atrial fibrillation burden?

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2018-09-09       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.